A carregar...
Bevacizumab and ovarian cancer
Bevacizumab is a recombinant humanized monoclonal IgG1 antibody that targets vascular endothelial growth factor-A, and is indicated in the treatment of various tumors (colon, lung, renal, and glioblastoma). It has been recently approved for the treatment of ovarian cancer in various countries. This...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3556875/ https://ncbi.nlm.nih.gov/pubmed/23450196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012467661 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|